445 related articles for article (PubMed ID: 19289772)
1. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
[No Abstract] [Full Text] [Related]
2. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
[No Abstract] [Full Text] [Related]
3. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
[No Abstract] [Full Text] [Related]
4. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
5. Standard treatment of advanced-stage diffuse large B-cell lymphoma.
Coiffier B
Semin Hematol; 2006 Oct; 43(4):213-20. PubMed ID: 17027655
[TBL] [Abstract][Full Text] [Related]
6. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
Miles SA; McGratten M
J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386
[No Abstract] [Full Text] [Related]
7. CHOP and rituximab in elderly patients.
Portlock CS
Curr Oncol Rep; 2002 Sep; 4(5):414. PubMed ID: 12162916
[No Abstract] [Full Text] [Related]
8. Aggressive lymphoma involving intracranial epidural region.
Villela LM; Blanco-Salazar A; Caballero R; Borbolla-Escoboza R
J Neurooncol; 2007 Jun; 83(2):181-2. PubMed ID: 17332949
[No Abstract] [Full Text] [Related]
9. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
10. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma.
Ferreri AJ; Dognini GP; Bairey O; Szomor A; Montalbán C; Horvath B; Demeter J; Uziel L; Soffietti R; Seymour JF; Ambrosetti A; Willemze R; Martelli M; Rossi G; Candoni A; De Renzo A; Doglioni C; Zucca E; Cavalli F; Ponzoni M;
Br J Haematol; 2008 Oct; 143(2):253-7. PubMed ID: 18699850
[TBL] [Abstract][Full Text] [Related]
11. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate antidiuretic hormone production in diffuse large B-cell lymphoma.
Kobayashi K; Yokote T; Akioka T; Takubo T; Tsuji M; Hanafusa T
Br J Haematol; 2008 Oct; 143(1):2. PubMed ID: 18513282
[No Abstract] [Full Text] [Related]
13. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
[No Abstract] [Full Text] [Related]
14. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous large B-cell leg-type lymphoma occurring on a leg burn].
Meziane M; Hesse S; Chetaille B; Bien-Aimée A; Grob JJ; Richard MA
Ann Dermatol Venereol; 2009 Nov; 136(11):791-4. PubMed ID: 19917431
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.
Wobser M; Kneitz H; Bröcker EB; Becker JC
J Dtsch Dermatol Ges; 2011 Mar; 9(3):204-11. PubMed ID: 21122066
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome.
Nakayama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Miyoshi T; Oka S; Hiraoka N; Iwaki K; Takayama A; Takubo T; Tsuji M; Hanafusa T
Eur J Haematol; 2010 Jan; 84(1):79-83. PubMed ID: 19558504
[TBL] [Abstract][Full Text] [Related]
18. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
19. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
[TBL] [Abstract][Full Text] [Related]
20. A male with primary breast lymphoma.
Miura Y; Nishizawa M; Kaneko H; Watanabe M; Tsudo M
Am J Hematol; 2009 Mar; 84(3):191-2. PubMed ID: 18932237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
